Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Share-based Compensation (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Share-based Compensation for 4 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 76.07% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, down 51.87% year-over-year, with the annual reading at $2.6 million for FY2025, 51.87% down from the prior year.
  • Share-based Compensation for Q4 2025 was $1.7 million at Spruce Biosciences, up from $415000.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $1.7 million in Q4 2025, with the low at -$77000.0 in Q2 2025.
  • Average Share-based Compensation over 4 years is $1.0 million, with a median of $1.1 million recorded in 2023.
  • Peak annual rise in Share-based Compensation hit 76.07% in 2025, while the deepest fall reached 104.57% in 2025.
  • Over 4 years, Share-based Compensation stood at $802000.0 in 2022, then skyrocketed by 52.24% to $1.2 million in 2023, then fell by 21.29% to $961000.0 in 2024, then surged by 76.07% to $1.7 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $1.7 million, $415000.0, and -$77000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.